Paul V, Krishnamoorthy M S
Department of Pharmacology & Environmental Toxicology, University of Madras.
Indian J Med Res. 1990 Feb;92:17-20.
The effect of propranolol was assessed against myoclonus induced by picrotoxin (a known GABA antagonist) in a dose of 3 mg/kg and allylglycine (the inhibitor of GABA synthesis and release) in a dose of 150 mg/kg. A dose-dependent (0.5-2 mg/kg) protective effect was found against both models. Pretreatment of rats with a GABA-reducing dose (100 mg/kg, nonmyoclonic) of allylglycine produced no change in the effect of propranolol against picrotoxin-induced myoclonus. Propranolol thus inhibited myoclonic responses when both the receptor activity and the functional pool of GABA were impaired, suggesting that it produces as antimyoclonic action without the involvement of GABA. However, the drug seems to show a synergistic action with GABA-ergic agents, as greater protection was observed in rats treated concurrently with propranolol and amino-oxyacetic acid, an inhibitor of GABA degradation.
评估了普萘洛尔对由剂量为3mg/kg的苦味毒(一种已知的GABA拮抗剂)和剂量为150mg/kg的烯丙基甘氨酸(GABA合成和释放抑制剂)诱导的肌阵挛的作用。发现对两种模型均有剂量依赖性(0.5 - 2mg/kg)的保护作用。用降低GABA剂量(100mg/kg,无肌阵挛)的烯丙基甘氨酸预处理大鼠,普萘洛尔对苦味毒诱导的肌阵挛的作用没有变化。因此,当GABA的受体活性和功能库均受损时,普萘洛尔抑制了肌阵挛反应,这表明它产生抗肌阵挛作用而不涉及GABA。然而,该药物似乎与GABA能药物表现出协同作用,因为在同时用普萘洛尔和GABA降解抑制剂氨基氧乙酸治疗的大鼠中观察到了更大的保护作用。